Elsterova, Jana and Palus, Martin and Sirmarova, Jana and Kopecky, Jan and Niller, Hans Helmut and Ruzek, Daniel (2017) Tick-borne encephalitis virus neutralization by high dose intravenous immunoglobulin. TICKS AND TICK-BORNE DISEASES, 8 (2). pp. 253-258. ISSN 1877-959X, 1877-9603
Full text not available from this repository. (Request a copy)Abstract
Tick-borne encephalitis (TBE) is a potentially lethal neuroinfection in humans, caused by TBE virus (TBEV). Currently, there are no approved therapeutic agents to treat TBE. Previously, it was suggested that application of high dose intravenous immunoglobulin (IVIG) may pose potentially successful treatment for severe cases of TBE. In this study, we determined the titers of TBEV-neutralizing antibodies in two IVIG lots originating from the same manufacturer, and tested their ability to treat a lethal TBEV-infection in a mouse model. Using an in vitro assay, more than 100-fold difference in TBEV-neutralizing capacity was demonstrated between the two individual IVIG lots. High TBEV-heutraliZing activity of IVIG containing TBEV-specific antibody was confirmed in two different human neural cell lines, but IVIG without TBEV-specific antibodies had no or little effect on virus titers in the culture. In TBEV-infected mice, 90% of protection was achieved when the mice were treated with IVIG containing higher titers of TBEV-specific antibodies, whereas no immunotherapeutic effect was seen When mice were treated with IVIG without TBEV-specific antibodies. No antibody-dependent enhancement of TBEV infectivity induced by cross-reactive antibodies or by virus-specific antibodies at neutralizing or sub-neutralizing levels was observed either in cell culture or in TBEV-infected mice treated with any of the IVIG preparations. The results indicate that IVIG lots with high TBEV antibody titers might represent a post-exposure prophylaxis or first-line effective therapy of patients with a severe form of TBE. (C) 2016 Elsevier GmbH. All rights reserved.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | INFECTION; GLOBULIN; ANTIBODY; ENHANCEMENT; ARBOVIRUSES; VACCINATION; PATIENT; CELLS; Flavivirus; Ticks; Neutralizing antibodies; IVIG; Antibody-dependent enhancement; Immunotherapy |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 14 Dec 2018 12:58 |
| Last Modified: | 13 Feb 2019 14:09 |
| URI: | https://pred.uni-regensburg.de/id/eprint/113 |
Actions (login required)
 |
View Item |
